PLX Archived Articles

Protalix BioTherapeutics: A Pioneer in Plant Cell-Based Protein Expression


Protalix BioTherapeutics (PLX): Leveraging the Power of Plant-Based Protein Expression for Rare Disease Therapies


ProCell Opportunity: Protalix BioTherapeutics (NYSE American: PLX)